| Title | Prostate Cancer |
| Abbreviation | Prostate Cancer |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Oncology (Q3); Urology (Q3); Cancer Research (Q4) |
| h-index | 14 |
| Overall Rank/Ranking | 13362 |
| SCImago Journal Rank (SJR) | 0.364 |
| Impact Score | 1.17 |
| Publisher | Hindawi Limited |
| Country | Egypt |
| ISSN | 20903111, 2090312X |
| Best Quartile | Q3 |
| Coverage History | 2011, 2013-2022 |
Prostate Cancer is a journal covering the technologies/fields/categories related to Oncology (Q3); Urology (Q3); Cancer Research (Q4). It is published by Hindawi Limited. The overall rank of Prostate Cancer is 13362. According to SCImago Journal Rank (SJR), this journal is ranked 0.364. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 14. The best quartile for this journal is Q3.
The ISSN of Prostate Cancer journal is 20903111, 2090312X. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Prostate Cancer is cited by a total of 53 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Prostate Cancer is 1.17, which is computed in 2023 as per its definition. Prostate Cancer IF is decreased by a factor of 0.6 and approximate percentage change is -33.9% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Prostate Cancer is 1.17. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 1.17 |
| 2021 | 1.77 |
| 2020 | 1.83 |
| 2019 | 3.20 |
| 2018 | 2.50 |
| 2017 | 2.68 |
| 2016 | 2.58 |
| 2015 | 0.25 |
| 2014 | 2.00 |
Prostate Cancer has an h-index of 14. It means 14 articles of this journal have more than 14 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Prostate Cancer is 20903111, 2090312X. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Prostate Cancer is 13362. According to SCImago Journal Rank (SJR), this journal is ranked 0.364. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.364 |
| 2021 | 0.321 |
| 2020 | 0.377 |
| 2019 | 0.703 |
| 2018 | 0.877 |
| 2017 | 0.890 |
| 2016 | 1.617 |
| 2015 | 0.150 |
| 2014 | 0.130 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 13362 |
| 2021 | 14180 |
| 2020 | 12682 |
| 2019 | 6939 |
| 2018 | 5239 |
| 2017 | 5121 |
| 2016 | 2071 |
| 2015 | 21046 |
| 2014 | 22804 |
Prostate Cancer is published by Hindawi Limited. It's publishing house is located in Egypt. Coverage history of this journal is as following: 2011, 2013-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Prostate Cancer is Prostate Cancer. This abbreviation ('Prostate Cancer') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Oncology (Q3); Urology (Q3); Cancer Research (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Prostate Cancer latest impact IF is 1.17. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 3.20 (2019) and 0.25 (2015), respectively, in the last 9 years. Moreover, its average IS is 2 in the previous 9 years.
The Prostate Cancer has an SJR (SCImago Journal Rank) of 0.364, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.617 in 2016 and the lowest being 0.130 in 2014. Furthermore, the average SJR of the Prostate Cancer over the previous 9-year period stands at 2.
The latest h-index of the Prostate Cancer is 14.
The Prostate Cancer is published by the Hindawi Limited, with its country of publication being the Egypt.
The Prostate Cancer is currently ranked 13362 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 2071 in 2016 and its lowest position of 22804 in 2014.
The standard ISO4 abbreviation for the Prostate Cancer is Prostate Cancer.
Prostate Cancer is classified as a journal that the Hindawi Limited publishes.
The Prostate Cancer encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Prostate Cancer is assigned the following International Standard Serial Numbers (ISSN): 20903111, 2090312X.
The best quartile for the Prostate Cancer is Q3 (2022).
The Prostate Cancer coverage history can be summarized as follows: 2011, 2013-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Academic Ethics | journal | 8920 | Springer Netherlands | 26 | 2.28 |
| Zeitschrift fur Germanistische Linguistik | journal | 22945 | De Gruyter Mouton | 15 | 0.19 |
| Business: Theory and Practice | journal | 13414 | Vilnius Gediminas Technical University | 21 | 2.47 |
| Archives of Phytopathology and Plant Protection | journal | 14852 | Taylor and Francis Ltd. | 29 | 1.14 |
| Air and Space Power Journal (discontinued) | journal | 28397 | AU Press | 9 | 0.20 |
| Transnational Corporations | journal | 6120 | UNCTAD United Nations Conference on Trade and Development | 27 | 1.92 |
| Oral Radiology | journal | 9461 | Springer Japan | 20 | 2.06 |
| SPE International Formation Damage Control Symposium Proceedings | conference and proceedings | 21934 | 16 | 0.00 | |
| HOMO- Journal of Comparative Human Biology | journal | 19810 | Elsevier BV | 35 | 0.56 |
| Journal of Tropical Agriculture | journal | 16120 | Kerala Agricultural University | 17 | 0.60 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 1.17 |
| 2021 | 1.77 |
| 2020 | 1.83 |
| 2019 | 3.20 |
| 2018 | 2.50 |
| 2017 | 2.68 |
| 2016 | 2.58 |
| 2015 | 0.25 |
| 2014 | 2.00 |
